Loading...
RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Lilly Eli & Co

Highlights

A collection of news and information related to Lilly Eli & Co published by this site and its partners.

Sort By: Relevancy | Date | Type
Displaying items 1-12 of 237
» View baltimoresun.com items only
    Jun 19, 2013 |Story| Reuters
  1. Medicamento para diabetes de AstraZeneca y Bristol decepciona en ensayo clave

    Reuters
    LONDRES (Reuters) - El medicamento de AstraZeneca y Bristol-Myers Squibb para la diabetes Onglyza no logró reducir los riesgos cardíacos en un importante estudio clínico, decepcionando a inversores que habían pensado que demostraría una ventaja sobre...

    Tags: AstraZeneca Plc, Placebo, Bristol Myers Squibb Company, Januvia (drug), Merck & Company Incorporated

  2. Jun 19, 2013 |Story| Reuters
  3. AstraZeneca, Bristol diabetes drug disappoints in key test

    Reuters
    LONDON (Reuters) - AstraZeneca and Bristol-Myers Squibb's diabetes drug Onglyza failed to reduce heart risks in a large clinical study, disappointing investors who had thought it might demonstrate an edge over rivals. The companies, which jointly sell...

    Tags: AstraZeneca Plc, Placebo, Stroke, Pharmaceuticals, Januvia (drug)

  4. Jun 18, 2013 |Story| Reuters
  5. FDA probes deaths of two patients on Lilly schizophrenia drug

    Reuters
    (Reuters) - The U.S. Food and Drug Administration is investigating the cases of two individuals who died after injections with Eli Lilly and Co.'s long-acting treatment for schizophrenia, Zyprexa Relprevv. Both patients died three to four days after...

    Tags: Stock Market, New York University, NYSE Euronext, Inc., Mental Illness, Johnson & Johnson Inc.

  6. Jun 18, 2013 |Story| Reuters
  7. EEUU indaga muerte de dos pacientes tras uso de fármaco para esquizofrenia de Lilly

    Reuters
    Por Ransdell Pierson (Reuters) - La Administración de Alimentos y Medicamentos de Estados Unidos (FDA por su sigla en inglés) está investigando la muerte de dos pacientes que fueron tratados con el medicamento inyectable de acción prolongada para...

    Tags: Johnson & Johnson Inc., Food and Drug Administration, Zyprexa (drug)

  8. Jun 18, 2013 |Story| Reuters
  9. EEUU estudia muerte de dos pacientes tras uso de fármaco para esquizofrenia de Eli Lilly

    Reuters
    18 jun (Reuters) - La Administración de Alimentos y Medicamentos de Estados Unidos (FDA por su sigla en inglés) dijo el martes que está investigando la muerte de dos pacientes tras ser tratados con el medicamento inyectable de acción prolongada para...

    Tags: Zyprexa (drug)

  10. Jun 18, 2013 |Story| Reuters
  11. CORRECTED-FDA studying deaths of two patients on Lilly's long-acting Zyprexa

    Reuters
    (Corrects headline to FDA studying, rather than Lilly) June 18 (Reuters) - The U.S. Food and Drug Administration on Tuesday said it was investigating deaths of two patients who died following injections with Eli Lilly and Co's long-acting treatment...

    Tags: Schizophrenia, Zyprexa (drug), Food and Drug Administration

  12. Jun 18, 2013 |Story| Reuters
  13. J&J studying deaths of two patients on long-acting Zyprexa

    Reuters
    June 18 (Reuters) - The U.S. Food and Drug Administration on Tuesday said it was investigating deaths of two patients who died following injections with Eli Lilly and Co's long-acting treatment for schizophrenia, called Zyprexa Relprevv. The agency said...

    Tags: Schizophrenia, Zyprexa (drug), Food and Drug Administration

  14. Jun 17, 2013 |Story| Reuters
  15. Novo Nordisk shares hit by concerns over rival diabetes drugs

    Reuters
    COPENHAGEN (Reuters) - Novo Nordisk , the world's biggest insulin producer, faces more competition in the diabetes field from rivals Eli Lilly and Sanofi , both of which will showcase new products at an upcoming medical meeting. Shares in the Danish...

    Tags: Medical Procedures and Tests, Lantus (drug), Pharmaceuticals, Drugs and Medicines, Chemical Industry

  16. Jun 13, 2013 |Story| Reuters
  17. Lilly halts Alzheimer's drug trial due to liver problems

    Reuters
    (Reuters) - Eli Lilly and Co. said on Thursday it halted a mid-stage study of an experimental Alzheimer's disease treatment due to potential liver toxicity, the latest setback in the quest to find a treatment that can slow or cure the memory-robbing...

    Tags: Alzheimer's Disease, Diseases and Illnesses, Roche Holding AG, Merck & Company Incorporated, Trials

  18. Jun 13, 2013 |Story| Reuters
  19. Lilly halts Alzheimer's drug trial because of liver problems

    Reuters
    June 13 (Reuters) - Eli Lilly and Co said on Thursday it was halting a midstage clinical trial of an experimental Alzheimer's disease treatment due to potential liver toxicity problems. It was the latest setback in the quest to find a treatment that...

    Tags: Alzheimer's Disease, Diseases and Illnesses

  20. Jun 13, 2013 |Story| Reuters
  21. Lilly says arthritis pill effective in mid-stage study

    Reuters
    (Reuters) - Eli Lilly and Co and Incyte Corp said their experimental drug was effective in reducing painful symptoms associated with rheumatoid arthritis after 52 weeks of treatment. The drug, baricitinib, is part of a new family of medicines called...

    Tags: Stock Market, NASDAQ, Rheumatoid Arthritis, NYSE Euronext, Inc., Arthritis

  22. Jun 12, 2013 |Story| South Bend Tribune
  23. Voice of the People: Corporations must pay fair share

    I was outraged after recently hearing of Apple avoiding $9 billion in U.S. taxes by hiding its money overseas in a tax haven in Ireland.
    I was outraged after recently hearing of Apple avoiding $9 billion in U.S. taxes by hiding its money overseas in a tax haven in Ireland. Even though Congress recently held hearings about Apple's tax transgressions, many other companies continue to avoid...

    Tags: Sandy Hook Elementary School, Barack Obama, Hurricane Sandy (2012), U.S. Congress, Patents, Copyrights and Trademarks

 1  2 3 4 5 6 7 8 9 10 11-20Next >
Original site for Lilly Eli & Co topic gallery.
Loading...
 
 

Date:

Credit:

User-submitted

Tags:

Rate:
Sending...

E-mail this photo

Error: malformed email address(es)
Both "from" and "recipient" email fields are required.

Recipient E-mail Addresses

(up to 3, separated by commas) Send me a copy.

From:

e-mail | buy this photo | link to photo
Lilly Eli & Co Photos
Eli Lilly headquarters in Indianapolis.
(June 18, 2013)
Eli Lilly headquarters
Governor Pence joins representatives from Covance, Eli...
(June 5, 2013)
Gov.. Pence
Sears Holdings said Jeff Balagna will join the company...
(May 14, 2013)
Jeff Balagna, executive vice president and chief information officer, Sears Holdings